tiprankstipranks
Advertisement
Advertisement

USANA Health Q1 2026 Results Highlight Mixed Performance

Story Highlights
  • USANA posted flat Q1 2026 sales but lower earnings, while reaffirming its annual guidance.
  • Greater China and fast-growing Rise Wellness offset declines elsewhere, underscoring USANA’s omnichannel pivot.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
USANA Health Q1 2026 Results Highlight Mixed Performance

Meet Samuel – Your Personal Investing Prophet

USANA Health ( (USNA) ) has issued an announcement.

USANA Health Sciences reported flat first-quarter 2026 net sales of $250 million versus a year earlier, but net earnings fell 20% to $7.5 million and diluted EPS declined to $0.41, reflecting margin and customer pressures across core operations. Core Nutritional net sales slipped 3% to $204 million with active customers down 12% year over year, and Hiya Health revenue and subscribers also contracted, although consolidated results showed sequential improvement and the company reiterated its full-year 2026 guidance.

Geographically, Greater China delivered 4% net sales growth to $123 million and strong sequential gains in customers, partly offsetting double-digit declines in North Asia, Southeast Asia Pacific, and the Americas and Europe. Rise Wellness emerged as a key growth driver with net sales surging 741% year over year to $14 million as its Protein Pop product expanded nationwide at Costco, helping reduce inventories and demonstrating the potential of USANA’s omnichannel strategy to diversify revenue and support its transformation despite ongoing customer attrition in legacy markets.

The most recent analyst rating on (USNA) stock is a Hold with a $39.00 price target. To see the full list of analyst forecasts on USANA Health stock, see the USNA Stock Forecast page.

Spark’s Take on USNA Stock

According to Spark, TipRanks’ AI Analyst, USNA is a Neutral.

USNA scores below average primarily due to weakened cash flow and sharply lower profitability despite a strong, low-leverage balance sheet. Technicals add downside pressure with the stock trading below major moving averages and negative momentum. Guidance and retail expansion plans provide some offset, but elevated inventory, margin mix pressure, and high tax-rate guidance constrain the overall score.

To see Spark’s full report on USNA stock, click here.

More about USANA Health

USANA Health Sciences, Inc. is a health and wellness company that is transitioning from a single-channel direct sales model into a diversified omnichannel platform. Its core nutritional segment focuses on dietary supplements and related products, while newer businesses Hiya Health and Rise Wellness extend its reach into subscription-based offerings and retail channels, including major warehouse retailers in the U.S. and abroad.

Average Trading Volume: 128,126

Technical Sentiment Signal: Strong Sell

Current Market Cap: $342.6M

For detailed information about USNA stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1